KEGG   DRUG: Human papillomavirus 9-valent vaccine, recombinant
Entry
D11863                      Drug                                   
Name
Human papillomavirus 9-valent vaccine, recombinant;
Recombinant adsorbed 9-valent human papillomavirus virus-like particle vaccine (yeast origin);
Gardasil 9 (TN);
Silgard 9 (TN)
Product
Remark
Therapeutic category: 6313
ATC code: J07BM03
Product: D11863<JP/US>
Efficacy
Active immunization (papillomavirus)
  Disease
Cervical cancer [DS:H00030]
Vulvar cancer [DS:H00029]
Oropharyngeal cancer [DS:H01559]
Anal cancer [DS:H00044]
Head and neck cancer [DS:H02420]
Genital warts [DS:H01418]
Comment
Prevention of diseases caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BM Papillomavirus vaccines
     J07BM03 Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
      D11863  Human papillomavirus 9-valent vaccine, recombinant <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Human Papillomavirus (HPV)
    Human Papillomavirus 9-valent Vaccine
     D11863  Human papillomavirus 9-valent vaccine, recombinant
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D11863  Human papillomavirus 9-valent vaccine, recombinant
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11863
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11863

» Japanese version   » Back

DBGET integrated database retrieval system